These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2309 related articles for article (PubMed ID: 17157791)

  • 1. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
    Neve RM; Chin K; Fridlyand J; Yeh J; Baehner FL; Fevr T; Clark L; Bayani N; Coppe JP; Tong F; Speed T; Spellman PT; DeVries S; Lapuk A; Wang NJ; Kuo WL; Stilwell JL; Pinkel D; Albertson DG; Waldman FM; McCormick F; Dickson RB; Johnson MD; Lippman M; Ethier S; Gazdar A; Gray JW
    Cancer Cell; 2006 Dec; 10(6):515-27. PubMed ID: 17157791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer.
    Jiang G; Zhang S; Yazdanparast A; Li M; Pawar AV; Liu Y; Inavolu SM; Cheng L
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):525. PubMed ID: 27556158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
    Chin K; DeVries S; Fridlyand J; Spellman PT; Roydasgupta R; Kuo WL; Lapuk A; Neve RM; Qian Z; Ryder T; Chen F; Feiler H; Tokuyasu T; Kingsley C; Dairkee S; Meng Z; Chew K; Pinkel D; Jain A; Ljung BM; Esserman L; Albertson DG; Waldman FM; Gray JW
    Cancer Cell; 2006 Dec; 10(6):529-41. PubMed ID: 17157792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells.
    Baumann J; Wong J; Sun Y; Conklin DS
    BMC Cancer; 2016 Jul; 16():551. PubMed ID: 27464732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.
    Bravatà V; Cava C; Minafra L; Cammarata FP; Russo G; Gilardi MC; Castiglioni I; Forte GI
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail".
    Menéndez JA; Vázquez-Martín A; Ropero S; Colomer R; Lupu R
    Clin Transl Oncol; 2006 Nov; 8(11):812-20. PubMed ID: 17134970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic subtypes in choosing adjuvant therapy for breast cancer.
    Zelnak AB; O'Regan RM
    Oncology (Williston Park); 2013 Mar; 27(3):204-10. PubMed ID: 23687790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer.
    Chandler P; Kochupurakkal BS; Alam S; Richardson AL; Soybel DI; Kelleher SL
    Mol Cancer; 2016 Jan; 15():2. PubMed ID: 26728511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
    Palomeras S; Diaz-Lagares Á; Viñas G; Setien F; Ferreira HJ; Oliveras G; Crujeiras AB; Hernández A; Lum DH; Welm AL; Esteller M; Puig T
    Breast Cancer Res; 2019 Jul; 21(1):79. PubMed ID: 31277676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do breast cancer cell lines provide a relevant model of the patient tumor methylome?
    Cope LM; Fackler MJ; Lopez-Bujanda Z; Wolff AC; Visvanathan K; Gray JW; Sukumar S; Umbricht CB
    PLoS One; 2014; 9(8):e105545. PubMed ID: 25157401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles.
    Sun Y; Liu Q
    Biomed Res Int; 2015; 2015():901303. PubMed ID: 26273658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origins of breast cancer subtypes and therapeutic implications.
    Sims AH; Howell A; Howell SJ; Clarke RB
    Nat Clin Pract Oncol; 2007 Sep; 4(9):516-25. PubMed ID: 17728710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel subtype classification and risk of breast cancer by histone modification profiling.
    Chen X; Hu H; He L; Yu X; Liu X; Zhong R; Shu M
    Breast Cancer Res Treat; 2016 Jun; 157(2):267-279. PubMed ID: 27178334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines.
    Chae H; Lee S; Nephew KP; Kim S
    BMC Syst Biol; 2016 Dec; 10(Suppl 4):116. PubMed ID: 28155687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
    Jhan JR; Andrechek ER
    Oncogene; 2017 Jun; 36(25):3553-3561. PubMed ID: 28135251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems biology and genomics of breast cancer.
    Perou CM; Børresen-Dale AL
    Cold Spring Harb Perspect Biol; 2011 Feb; 3(2):. PubMed ID: 21047916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data.
    Liu K; Newbury PA; Glicksberg BS; Zeng WZD; Paithankar S; Andrechek ER; Chen B
    Nat Commun; 2019 May; 10(1):2138. PubMed ID: 31092827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling precision treatment of breast cancer.
    Daemen A; Griffith OL; Heiser LM; Wang NJ; Enache OM; Sanborn Z; Pepin F; Durinck S; Korkola JE; Griffith M; Hur JS; Huh N; Chung J; Cope L; Fackler MJ; Umbricht C; Sukumar S; Seth P; Sukhatme VP; Jakkula LR; Lu Y; Mills GB; Cho RJ; Collisson EA; van't Veer LJ; Spellman PT; Gray JW
    Genome Biol; 2013; 14(10):R110. PubMed ID: 24176112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.